Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion
The New England Journal of Medicine

An opinionated take on NEJM highlights for the fourth quarter of 2024

  • NEJM
Preempting severe genetic disease Around 2% of births come with a gene…

Read more